Protective anti-donor IgM production after crossmatch positive liver-kidney transplantation

Liver Transplantation

Volumn 10, Issue 2, 2004, Pages 315-319

  McAlister, Chloe C ^a   Gao, Zu Hua ^a   McAlister, Vivian C ^a,b   Gupta, Rekha ^a   Wright Jr , James R ^a   MacDonald, Allan S ^a   Peltekian, Kevork ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD GROUP TYPING; CASE REPORT; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT DEPOSITION; COMPLEMENT FIXATION; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN PRODUCTION; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LIVER POLYCYSTIC DISEASE; LIVER TRANSPLANTATION; MALE; ORGAN DONOR; PRIORITY JOURNAL; RECIPIENT; REOPERATION; SENSITIVITY ANALYSIS; SPLEEN CELL; T LYMPHOCYTE; TREATMENT OUTCOME;

ADULT; ANTIBODIES, ANTI-IDIOTYPIC; BLOOD GROUP INCOMPATIBILITY; COMPLEMENT C1Q; COMPLEMENT SYSTEM PROTEINS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KIDNEY; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 1242329508     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20062     Document Type: Article

References (14)

1. Starzl TE, Marchioro TL, Terasaki PI, Porter KA, Faris TD, Herrmann TJ, et al. Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg 1965;162:749-787.
2. Gordon RD, Fung JJ, Markus B, Fox I, Iwatsuki S, Esquivel CO. The antibody crossmatch in liver transplantation. Surgery. 1986; 100:705-715.
3. Saidman SL, Duquesnoy RJ, Demetris AJ, McCauley J. Ramos H, Mazariegos G, et al. Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol 1994; 2:61-67.
4. Neumann UP, Lang M, Moldenhauer A, Langrehr JM, Glanemann M, Kahl A, et al. Significance of a T-lymphocytotoxic crossmatch in liver and combined liver-kidney transplantation. Transplantation 2001;71:1163-1168.
5. Kimball P, Wagner B, King A, Fisher RA, Dawson S, Cotterell A, Posner M. Comparison of two drug regimens upon clinical outcome among renal transplant recipients with positive flow cytometric crossmatches. Clin Transplant 2002;16:290-294.
6. Iwaki Y, Lau M, Cook DJ, Takemoto S, Terasaki PI. Crossmatching with B and T cells and flow cytometry. Clin Transpl 1986;277-284.
7. Katznelson S, Cecka JM. The liver neither protects the kidney from rejection nor improves kidney graft survival after combined liver and kidney transplantation from the same donor. Transplantation 1996;61:1403-1405.
8. Fong TL, Bunnapradist S, Jordan SC, Selby RR, Cho YW. Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation. Transplantation 2003;76:348-353.
9. Mohanakumar T, Rhodes C, Mendez-Picon G, Flye MW, Lee HM. Antiidiotypic antibodies to human major histocompatibility complex class I and II antibodies in hepatic transplantation and their role in allograft survival. Transplantation 1987;44:54-58.
10. Spencer SC, Fabre JW. Bulk purification of a naturally occurring soluble form of RT1-A class I major histocompatibility complex from DA rat liver, and studies of specific immunosuppression. Transplantation 1987;44:141-148.
11. Chapman JR, Taylor CJ, Ting A, Morris PJ. Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Relationship to renal transplant outcome. Transplantation 1986;42:608-613.
12. McCalmon RT Jr, Tardif GN, Sheehan MA, Fitting K, Kortz W, Kam I. IgM antibodies in renal transplantation. Clin Transplant. 1997;11:558-564.
13. Kerman RH, Susskind B, Buyse I, Pryzbylowski P, Ruth J, Warnell S, et al. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome. Transplantation 1999;68:1855-1858.
14. Gao ZH, Gupta R, Wright JR, MacDonald AS, Xing JJ, McAlister VC. High serum concentration of donor-specific IgG3 antibody isotype in transplant rejection patients [abstract]. Am J Clin Pathol 2002;118:630.